VANCOUVER, BC, May 3, 2024
/CNW/ -
24/05/03 - TSX Venture
Exchange Stock Maintenance Bulletins
TSX VENTURE COMPANIES
BULLETIN V2024-1287
COPPER ROAD RESOURCES INC. ("CRD")
BULLETIN TYPE:
Declaration of Dividend, Remain Halted
BULLETIN DATE:
May 3, 2024
TSX Venture
Tier 2 Company
Copper Road Resources Inc. (the "Company") announced the sale of
the Copper Road Project (the "Target") to Sterling Metals Corp.
("Sterling"), pursuant to the terms of a definitive share purchase
agreement dated February 13, 2024
between the Company, Sterling and a wholly-owned subsidiary of the
Company (the " Subsidiary "), whereby Sterling will acquire the
Subsidiary, which will hold the Target, in consideration for
$460,000 cash payment and the
issuance of an aggregate of 108,087,683 common shares of Sterling
(the "Sterling Shares"), of which the Company will retain
21,838,123 Sterling Shares, representing approximately 9.9% of the
issued and outstanding common shares of Sterling post-closing of
the Target's acquisition, and distribute the remaining 86,249,560
Sterling Shares to its shareholders on pro rata basis.
In anticipation of the completion of the sale of the Target,
which is scheduled for May 10, 2024,
the Company has declared the following dividend on April 30, 2024:
|
Dividend per
Share:
|
1.461452795528613
shares of Sterling Metals Corp. per common share of the
Company
|
|
Payable Date:
|
May 10, 2024
|
|
Record Date:
|
May 8, 2024
|
Trading on the Company's common shares was halted on
April 30, 2024 to facilitate the
closing of the transaction and the distribution of Sterling's
shares. Trading will resume on an ex-distribution basis upon
completion of the disposition and distribution, and will be
confirmed in a separate bulletin.
For more information, please refer to the Company's press
releases dated February 14, 2024 and
April 30, 2024.
_______________________________________
BULLETIN V2024-1288
NEUTRISCI INTERNATIONAL INC.
("NU.H")
[formerly NeutriSci International Inc.
("NU")]
BULLETIN TYPE: Transfer and New Addition to NEX,
Symbol Change
BULLETIN DATE: May
3, 2024
TSX Venture Tier 2 Company
In accordance with TSX Venture Policy 2.5, the Company has not
maintained the requirements for a TSX Venture Tier 2 company.
Therefore, effective at the opening on Tuesday, May 7, 2024, the Company's listing
will transfer to NEX, the Company's Tier classification will change
from Tier 2 to NEX, and the Filing and Service Office will change
from Vancouver to NEX.
As of May 7, 2024, the Company is
subject to restrictions on share issuances and certain types of
payments as set out in the NEX policies.
The trading symbol for the Company will change from NU to
NU.H. There is no change in the Company's name, no change in
its CUSIP number and no consolidation of capital. The symbol
extension differentiates NEX symbols from Tier 1 or Tier 2 symbols
within the TSX Venture market.
_______________________________________
NEX COMPANY
BULLETIN V2024-1289
KR INVESTMENT LTD. ("KR.H")
BULLETIN TYPE:
Delist
BULLETIN DATE: May 3,
2024
NEX Company
Effective at the close of business on May 06, 2024, the common shares of KR
Investment Ltd. (the "Company") will be delisted from TSX Venture
Exchange at the request of the Company. The Company obtained the
approval for delisting by director's resolution on April 24, 2024, and the majority of minority
shareholder approval via written consent.
Upon delisting from TSXV, the Company's common shares
will be listed on the Canadian Securities Exchange (CSE)
at the start of trading on May 07,
2024.
For more information, please refer to the Company's news release
dated May 3, 2024.
_______________________________________
24/05/03 - TSX Venture Exchange
Bulletins
TSX VENTURE COMPANIES
BULLETIN V2024-1290
ABRASILVER RESOURCE CORP. ("ABRA")
BULLETIN
TYPE: Private Placement-Non-Brokered
BULLETIN
DATE: May 3, 2024
TSX
Venture Tier 2 Company
TSX Venture Exchange has accepted for filing documentation with
respect to a Non-Brokered Private Placement announced on
April 22, 2024:
|
Number of Shares:
|
50,000,000
shares
|
|
|
|
Purchase Price:
|
$0.40 per
share
|
|
|
|
Number of
Placees:
|
2 placees
|
|
|
Insider / Pro Group Participation: N/A
|
|
Aggregate
Cash
Amount
|
Aggregate
#
of
Shares
|
Aggregate
#
of
Warrants
|
|
Finder's
Fee:
|
$900,000
|
N/A
|
N/A
|
The Company issued a news release on April 26, 2024, confirming the closing of the
private placement.
_______________________________________
BULLETIN V2024-1291
ADVENTUS MINING CORPORATION ("ADZN")
BULLETIN
TYPE: Private Placement-Non-Brokered
BULLETIN
DATE: May 3, 2024
TSX
Venture Tier 2 Company
TSX Venture Exchange has accepted for filing documentation with
respect to a Non-Brokered Private Placement announced on
April 26, 2024:
|
Number of Shares:
|
67,441,217
shares
|
|
|
|
Purchase Price:
|
$0.38 per
share
|
|
|
|
Number of
Placees:
|
1 placee
|
|
|
Insider / Pro Group Participation: N/A
|
|
|
Finder's Fee: N/A
|
The Company issued a news release on May
1, 2024, confirming the closing of the private
placement.
_______________________________________
BULLETIN V2024-1292
ADYTON RESOURCES CORPORATION ("ADY")
BULLETIN
TYPE: Private Placement-Non-Brokered
BULLETIN
DATE: May 3, 2024
TSX
Venture Tier 1 Company
TSX Venture Exchange has accepted for filing documentation with
respect to a Non-Brokered Private Placement announced on
March 27, 2024 and April 15, 2024:
|
Number of Shares:
|
50,000,000
shares
|
|
|
|
Purchase Price:
|
$0.03 per
share
|
|
|
|
Number of
Placees:
|
25 placees
|
|
Insider / Pro Group Participation:
|
|
|
|
|
|
|
Placees
|
# of Placee
(s)
|
Aggregate # of
Shares
|
|
|
|
|
Aggregate Existing Insider
Involvement:
|
4
|
6,250,000
|
|
Aggregate Pro Group Involvement:
|
4
|
10,400,000
|
|
Aggregate
Cash
Amount
|
Aggregate
#
of
Shares
|
Aggregate
#
of
Warrants
|
|
Finder's Fee:
|
N/A
|
4,000,000
Shares
|
4,000,000
Warrants
|
Finder's Warrants Terms: Each warrant entitles the holder to
purchase one common share at the price of $0.05 for period of two years from the date of
issuance.
The Company issued a news release on April 19, 2024 confirming closing of the private
placement.
_______________________________________
BULLETIN V2024-1293
ADYTON RESOURCES CORPORATION ("ADY")
BULLETIN
TYPE: Shares for Debt
BULLETIN DATE:
May 3, 2024
TSX Venture
Tier 1 Company
TSX Venture Exchange has accepted for filing the Company's
proposal to issue 4,000,000 shares to settle outstanding debt for
$120,000.
Number of
Creditors:
3 Creditors
|
Non-Arm's Length Party
/
Pro Group
Participation:
|
|
|
|
|
|
|
|
|
|
|
Creditors
|
# of
Creditors
|
Amount
Owing
|
Deemed
Price
per
Share
|
Aggregate #
of
Shares
|
|
|
|
|
|
|
Aggregate
Non-Arm's
Length Party
Involvement:
|
3
|
$120,000
|
$0.03
|
4,000,000
|
|
Aggregate Pro
Group
Involvement:
|
N/A
|
N/A
|
N/A
|
N/A
|
For more information, please refer to the Company's news
releases dated January 19, 2024 and
April 29, 2024.
_______________________________________
BULLETIN V2024-1294
ANALYTIXINSIGHT INC. ("ALY") ("ALY.WT")
BULLETIN
TYPE: Halt
BULLETIN DATE: May 3, 2024
TSX Venture Tier 2
Company
Effective at 7:13 a.m. PST,
May 3, 2024, trading in the shares of
the Company was halted, pending news; this regulatory halt is
imposed by Investment Industry Regulatory Organization of
Canada, the Market Regulator of
the Exchange pursuant to the provisions of Section 10.9(1) of the
Universal Market Integrity Rules.
_______________________________________
BULLETIN V2024-1295
EMERGE COMMERCE LTD. ("ECOM")
BULLETIN TYPE:
Shares for Debt
BULLETIN DATE: May 3, 2024
TSX Venture Tier 1
Company
TSX Venture Exchange has accepted for filing the Company's
proposal to issue 360,629 common shares at a deemed price of
$0.135 per share, to settle
outstanding accrued and unpaid interest of CDN$48,685 owing on $2,781,000 principal amount of convertible
debentures, that were issued pursuant to a prospectus-convertible
debenture unit offering under a debenture indenture dated as of
November 24, 2022 and a supplemental
indenture dated as of April 29,
2024.
For further details, please refer to the Company's news release
dated April 29, 2024. The Company
shall issue a news release when the shares are issued and the debt
extinguished.
_______________________________________
BULLETIN V2024-1296
FOBI AI INC. ("FOBI")
BULLETIN TYPE:
Shares for Services
BULLETIN DATE: May 3, 2024
TSX Venture Tier 2
Company
TSX Venture Exchange has accepted for filing the Company's
proposal to issue 226,781 shares at $0.388 per share and 770,421 shares at a deemed
price of $0.076 per share, for
997,202 shares in the aggregate, in consideration of certain
services provided to the company pursuant to a services agreement
dated April 18, 2023.
Number of Service Providers: 1
|
Non-Arm's Length Party
/
Pro Group
Participation:
|
|
|
|
|
|
|
|
|
|
|
Creditors
|
# of
Creditors
|
Amount
Owing
|
Deemed
Price
per
Share
|
Aggregate #
of
Shares
|
|
|
|
|
|
|
Aggregate
Non-Arm's
Length Party
Involvement:
|
N/A
|
N/A
|
N/A
|
N/A
|
|
Aggregate Pro
Group
Involvement:
|
N/A
|
N/A
|
N/A
|
N/A
|
The Company issued a news release on April 19, 2023 announcing the agreement and
further news releases on June 28,
2023 and April 25, 2024 when
the shares were issued.
_______________________________________
BULLETIN V2024-1297
FOBI AI INC. ("FOBI")
BULLETIN TYPE:
Property-Asset or Share Purchase Agreement
BULLETIN
DATE: May 3, 2024
TSX
Venture Tier 2 Company
TSX Venture Exchange has accepted for filing documentation with
respect to the arm's length acquisition of the business assets and
intellectual property that is used to operate an arm's length
vendor's digital wallet agency based in Spain under the following terms:
|
CONSIDERATION
|
CASH
($)
|
SECURITIES
|
WORK
EXPENDITURES
(S)
|
|
Initial purchase
price
as on TSXV
approval
date
|
N.A.
|
476,126 common shares
("Initial
Purchase
Price")
|
N.A.
|
|
|
|
|
|
Before the
first
anniversary of
the
closing date
|
N.A.
|
Maximum of 1,559,844
common
shares ("Earn-Out
Payment")
|
N.A.
|
As additional consideration of the acquisition and in addition
to the Initial Purchase Price, the Company may pay 81,000 euros through the issuance of up to
1,559,844 common shares upon achievement of certain revenue targets
before the first anniversary of the closing date.
For further details, please refer to the Company's news releases
dated October 18, 2023 and
April 25, 2024.
_______________________________________
BULLETIN V2024-1298
HAWKEYE GOLD & DIAMOND
INC. ("HAWK")
BULLETIN TYPE: Private
Placement-Non-Brokered
BULLETIN DATE: May 3, 2024
TSX Venture Tier 2
Company
TSX Venture Exchange has accepted for filing documentation with
respect to a Non-Brokered Private Placement announced on
September 26, 2023:
|
Number of Shares:
|
1,200,000
shares
|
|
|
|
Purchase Price:
|
$0.05 per
share
|
|
|
|
Warrants:
|
600,000 share purchase
warrants to purchase 600,000 shares
|
|
|
|
Warrant Exercise
Price:
|
$0.10 for a two-year
period and subject to accelerated expiry
|
|
|
|
Number of
Placees:
|
4 placees
|
|
Insider / Pro Group Participation:
|
|
|
|
|
|
|
Placees
|
# of Placee
(s)
|
Aggregate # of
Shares
|
|
|
|
|
Aggregate Existing Insider Involvement:
|
NA
|
NA
|
|
|
|
|
Aggregate Pro Group Involvement:
|
NA
|
NA
|
|
Aggregate
Cash
Amount
|
Aggregate
#
of
Shares
|
Aggregate
#
of
Warrants
|
|
Finder's Fee:
|
$3,600
|
NA
|
NA
|
The Company issued a news release on May
2, 2024 confirming closing of the private
placement. Note that in certain circumstances the Exchange may
later extend the expiry date of the warrants, if they are less than
the maximum permitted term.
_______________________________________
BULLETIN V2024-1299
LSL PHARMA GROUP INC. ("LSL")
BULLETIN TYPE:
Private Placement-Brokered, Convertible
Debentures
BULLETIN DATE: May 3,
2024
TSX Venture Tier 2 Company
TSX Venture Exchange (the "Exchange") has accepted for filing
documentation with respect to a Brokered Private Placement
announced on September 21, 2023:
|
Convertible
Debentures:
|
$3,288,000 aggregate
principal amount of unsecured convertible debentures (the
"Debentures")
|
|
|
|
Conversion Price:
|
The principal amount is
convertible into common shares at a conversion price of $0.70 per
share (the "Conversion Price")
|
|
|
|
If, at any time
following the date that is 24 months from November 1, 2023, for the
preceding 20 consecutive trading days (i) the daily volume weighted
average trading price of the Class A Shares on the Exchange is
greater than 175% of the Conversion Price; and (ii) the average
daily volume of the Class A Shares traded on the Exchange is no
less than the number obtained when dividing the number of shares
issued upon conversion of the total amount of Debentures
outstanding by twenty (20), LSL Pharma Group Inc. (the "Company")
will have the option to convert all of the principal amount
outstanding of the Debentures at the Conversion Price with at least
thirty (30) days' prior written notice.
|
|
|
|
Maturity Date:
|
October 31, 2028 (the
"Maturity Date")
|
|
|
|
Interest Rate:
|
11% per annum (the
"Base Rate") payable in cash semi-annually on the last day of April
and October of each year with the first interest payment to be paid
on October 31, 2024 ("First Interest Payment Date"). Interest will
accrue from November 1, 2023 (the "Initial Closing Date") up to the
First Interest Payment Date at the Base Rate, compounding
semi-annually on the last day of April and October of each year
(the "Interest Period").
|
|
|
|
The annual interest
rate will be recalculated twice every year on April 30th and
October 31st of each year, starting April 30, 2025 (each an
"Interest Rate Review Date") until the Maturity Date, and shall be
equal to the Base Rate less 100 basis points (1.0%) for each
Business Objective (as defined below) achieved (the "Amended Base
Rate"). Upon achievement of a Business Objective (as defined
below), the Amended Base Rate will be effective as of the following
interest payment date of the Debentures (after April 30, 2025)
until the next interest payment date thereafter if Business
Objective 3 (as defined below) is achieved or until the Maturity
Date if a Business Objective 1 or 2 (as defined below) is
achieved.
|
|
|
|
Business Objectives
(each a "Business Objective"):
- Business Objective 1: the obtention by
the Company of FDA approval for its Steri-Med plant (one-time
business objective);
- Business Objective 2: the completion by the
Company of the acquisition of a business which: 1) complements the
Company's existing product offering and/or creates synergies with
the Company's existing business operations and 2) generated a
minimum of CAD$5.0 million in revenue during the last twelve-month
(12) period preceding the acquisition (one-time business
objective); or
- Business Objective 3: The Company generates a
minimum of CAD$30 million of revenue with a 20% EBITDA margin
during the fiscal period preceding the Interest Rate Review Date
(annual business objective). With respect to Business Objective 3,
the Company's financial performance and revenue shall be calculated
based on its audited financial statements and the Company's EBITDA
margin shall be calculated as EBITDA (not adjusted EBITDA), as
calculated in its audited financial statements, divided by its
revenue (the "Business Objective 3", and the "Business Objective 1
or 2" means the Business Objective other than Business Objective
3).
|
|
|
|
Early Redemption:
|
Subject to regulatory
approval and subject to any provisions of the Debenture Indenture,
the Company at its option, shall have the right to redeem, either
in whole at any time or in part from time to time before the
Maturity Date (as defined below) by payment of money, the
debentures at a price per Debenture equal to: (i) 110% of the
principal amount plus accrued and unpaid interest if redeemed prior
to November 1, 2027; (ii) 102% of the principal amount plus accrued
and unpaid interest if redeemed on or after November 1, 2027 , but
prior to the Maturity Date; or (iii) in the event redemption of the
Debentures is required to secure financing for a bona fide
acquisition, (A) 105% of the principal amount plus accrued and
unpaid interest if redeemed prior to November 1, 2024 , (B)
104% of the principal amount plus accrued and unpaid interest if
redeemed on or after November 1, 2024 but prior to November 1, 2025
, and (C) 102% of the principal amount plus accrued and unpaid
interest if redeemed on or after November 1, 2025 but prior
to the Maturity Date (the "Redemption Price"). If partial
redemption of the Debentures is carried out prior to the Maturity
Date, the Redemption Price shall only apply to that portion of the
principal amount of the Debentures that is being
redeemed.
|
For more information, please consult the debenture indenture
dated November 1, 2023 available on
www.sedarplus.ca (the "Debenture Indenture").
Number of Placees:
322 placees
|
Insider / Pro Group
Participation:
|
|
|
|
|
|
|
Placees
|
# of Placee
(s)
|
Total principal of
convertible
debentures
($)
|
|
|
|
|
Aggregate Existing
Insider Involvement:
|
1
|
$85,000
|
|
Aggregate Pro Group
Involvement:
|
1
|
$20,000
|
|
Agent's Fee:
|
iA Capital Markets
received as compensation $222,660 in cash and 318,085 broker
warrants to purchase 318,085 common shares at a price of $0.70 per
share for a period of 24 months.
|
The Company has confirmed the closing of the Private Placement
in news releases dated November 1,
2023 and December 8, 2023.
GROUPE LSL PHARMA INC. (« LSL »)
TYPE DE
BULLETIN : Placement privé par l'entremise d'un courtier,
Débentures convertibles
DATE DU BULLETIN : Le 3 mai
2024
Société du groupe 2 de TSX Croissance
Bourse de croissance TSX (la « Bourse ») a accepté le dépôt de
la documentation de la société en vertu d'un placement privé par
l'entremise d'un courtier annoncé le 21 septembre 2023 :
|
Débentures convertibles
:
|
Débentures convertibles
non garanties pour un montant principal total de 3
288 000 $ (les « débentures »)
|
|
|
|
Prix de conversion
:
|
Le capital est
convertible en actions ordinaires à un prix de conversion de
0,70 $ par action (le « prix de
conversion »)
|
|
|
|
Si, à tout moment après
la date qui tombe 24 mois après le 1 novembre 2023, pendant les 20
jours de négociation à la bourse consécutifs précédents, (i) le
cours moyen pondéré en fonction du volume quotidien des actions de
catégorie A à la Bourse est supérieur à 175 % du prix de
conversion, et (ii) le volume quotidien moyen des actions de
catégorie A négociées à la Bourse n'est pas inférieur au nombre
obtenu en divisant par vingt (20) le nombre d'actions émises lors
de la conversion du montant total des débentures en circulation,
Groupe LSL Pharma Inc. (la « société » ) aura
l'option de convertir la totalité du capital des débentures en
circulation au prix de conversion, moyennant un préavis écrit d'au
moins trente (30) jours.
|
|
|
|
Date d'échéance :
|
31 octobre 2028 (la
« date d'échéance »)
|
|
|
|
Taux d'intérêt :
|
11% par année (le
« taux de base »), payable en espèces semestriellement le
dernier jour d'avril et d'octobre de chaque année, le premier
paiement d'intérêt devant être effectué le 31 octobre 2024 («
première date de paiement d'intérêt »). Les intérêts courront à
partir du 1er novembre 2023 (la « date de clôture initiale »)
jusqu'à la première date de paiement d'intérêt au taux de base,
composés semestriellement le dernier jour d'avril et d'octobre de
chaque année (la « période d'intérêt »).
|
|
|
|
Le taux d'intérêt
annuel sera recalculé deux fois par an, le 30 avril et le 31
octobre de chaque année, à partir du 30 avril 2025 (chacune étant
une « date de révision du taux d'intérêt ») jusqu'à la date
d'échéance, et sera égal au taux de base moins 100 points de base
(1,0%) pour chaque objectif commercial (tel que défini ci-dessous)
atteint (le « taux de base modifié »). Lorsqu'un objectif
commercial est atteint, le taux de base modifié sera effectif à
partir de la date de paiement d'intérêts suivante des débentures
(après le 30 avril 2025) jusqu'à la prochaine date de paiement
d'intérêts par la suite si l'objectif commercial 3 (tel que défini
ci-dessous) est atteint ou jusqu'à la date d'échéance si l'objectif
commercial 1 ou 2 (tel que défini ci-dessous) est
atteint.
|
|
|
|
Objectifs commerciaux
(chacun étant un « objectif commercial ») :
- Objectif commercial 1 : l'obtention par
la société de l'approbation de la FDA pour son usine Steri-Med
(objectif commercial ponctuel) ;
- Objectif commercial 2 : la réalisation
par la société de l'acquisition d'une entreprise qui : (1) complète
l'offre de produits existante de la société et/ou crée des
synergies avec les opérations commerciales existantes de la société
; et (2) a généré un minimum de 5,0 M$ CAD de revenus au cours des
douze (12) derniers mois précédant l'acquisition (objectif
commercial ponctuel) ; ou
- Objectif commercial 3 : la société
génère un minimum de 30 M$ CAD de revenus avec une marge du BAIIA
de 20 % au cours de l'exercice financier précédant la date de
révision du taux d'intérêt (objectif commercial annuel). En ce qui
concerne l'objectif commercial 3, la performance financière et le
chiffre d'affaires de la société sont calculés sur la base de ses
états financiers audités et la marge EBITDA de la société
correspond à l'EBITDA (et non à l'EBITDA ajusté), tel que calculé
dans ses états financiers audités, divisé par son chiffre
d'affaires (l'« objectif commercial 3 », et l'
« objectif commercial 1 ou 2 » désigne l'objectif commercial
autre que l'objectif commercial 3).
|
|
|
|
Remboursement anticipé
:
|
Sous réserve de
l'approbation réglementaire et de toute disposition de l'acte de
débentures, la société, à son gré, aura le droit de rembourser,
soit en totalité à tout moment, soit en partie de temps à autre
avant la date d'échéance (telle que définie ci-dessous ) par
paiement en espèce, les débentures à un prix par débenture égal
à : (i) 110 % du capital plus les intérêts courus et
impayés si remboursés avant le 1 novembre 2027,; (ii) 102 % du
montant en capital majoré des intérêts courus et impayés en cas de
remboursement le 1 novembre 2027 ou après, , mais avant la date
d'échéance ; ou (iii) dans le cas où le remboursement des
débentures est requis pour garantir le financement d'une
acquisition véritable, (A) 105 % du capital plus les intérêts
courus et impayés en cas de remboursement avant le 1 novembre 2024,
(B) 104 % du montant en principal plus les intérêts courus et
impayés en cas de remboursement à compter du
1 novembre 2024, , mais avant le
1 novembre 2025, , et (C) 102 % du montant en capital
majoré des intérêts courus et impayés en cas de remboursement à
compter du 1 novembre 2025, mais avant la date d'échéance (le «
prix de remboursement »). Si le remboursement partiel des
débentures est effectué avant la date d'échéance, le prix de
remboursement s'appliquera uniquement à la partie du capital des
débentures qui est remboursée.
|
Pour plus d'information, veuillez consulter l'acte de débentures
daté du 1er novembre 2023 disponible sur
www.sedarplus.ca (l' « acte de débentures »).
Nombre de
souscripteurs :
322 souscripteurs
|
Souscripteurs
|
# de
souscripteurs:
|
Montant total du
principal des
débentures
convertibles ($)
|
|
Participation total
d'initiés
existants:
|
1
|
85 000 $
|
|
Participation total de
Groupe Pro:
|
1
|
20 000 $
|
|
Rémunération de l'agent
:
|
iA Capital Markets a
reçu comme compensation 222 660 $ en espèces et 318 085 bons de
rémunération permettant de souscrire à 318 085 actions ordinaires à
un prix de 0,70 $ par action pour une période de 24
mois.
|
La société a confirmé la clôture du placement privé dans des
communiqués de presses datés du 1 novembre 2023 et du 8 décembre 2023.
_______________________________________
BULLETIN V2024-1300
MINILUXE HOLDING
CORP. ("MNLX")
BULLETIN TYPE: Shares for
Bonuses
BULLETIN DATE: May 3,
2024
TSX Venture Tier 2 Company
TSX Venture Exchange (the "Exchange") has accepted for filing an
Amendment to Loan and Security Agreement dated April 5, 2024, between the Company and Flow
Capital Corp. (the "Lender"), whereby the Company will advance an
additional USD $2,000,000 from its
initial term debt investment of USD $2,500,000 in 2021 (the "Loan"). The Loan carries
an interest rate of 15% per annum and shall mature on April 30, 2027. Additionally, the Exchange has
accepted the issuance of 1,692,308 non-transferable bonus warrants
to be issued to the Lender in connection with the Loan. Each
warrant is exercisable into one common share at a price of
US$0.52 three years after the
effective date of the debenture.
For further details, please refer to the Company's news releases
dated April 9, 2024.
_______________________________________
BULLETIN V2024-1301
PANTERA SILVER CORP. ("PNTR")
BULLETIN
TYPE: Warrant Term Extension
BULLETIN DATE:
May 3, 2024
TSX Venture
Tier 2 Company
TSX Venture Exchange has consented to the extension in the
expiry date of the following warrants:
Private Placement:
|
# of Warrants:
|
10,298,500
|
|
Original Expiry Date of
Warrants:
|
March 11,
2024
|
|
New Expiry Date of
Warrants:
|
March 11,
2025
|
|
Exercise Price of
Warrants:
|
$0.20
(Unchanged)
|
These warrants were issued pursuant to a private placement of
10,423,500 shares with 10,423,500 share purchase warrants attached,
which was accepted for filing by the Exchange effective
March 9, 2021.
_______________________________________
BULLETIN V2024-1302
PLAYGON GAMES INC. ("DEAL")
BULLETIN TYPE:
Shares for Debt
BULLETIN DATE: May 3, 2024
TSX Venture Tier 2
Company
TSX Venture Exchange has accepted for filing the Company's
proposal to issue 4,234,553 shares to settle outstanding debt for
$127,036.59.
Number of
Creditors:
6 Creditors
|
Non-Arm's Length Party
/
Pro Group
Participation:
|
|
|
|
|
|
|
|
|
|
|
Creditors
|
# of
Creditors
|
Amount
Owing
|
Deemed
Price
per
Share
|
Aggregate #
of
Shares
|
|
|
|
|
|
|
Aggregate
Non-Arm's
Length Party
Involvement:
|
3
|
$121,286.68
|
$0.03
|
4,042,887
|
|
Aggregate Pro
Group
Involvement:
|
N/A
|
N/A
|
N/A
|
N/A
|
Please refer to the Company's news release dated April 29, 2024 for further details.
_______________________________________
BULLETIN V2024-1303
REX RESOURCES CORP. ("OWN")
BULLETIN TYPE:
Private Placement-Non-Brokered
BULLETIN DATE:
May 3, 2024
TSX Venture
Tier 2 Company
TSX Venture Exchange has accepted for filing documentation with
respect to a Non-Brokered Private Placement announced on
April 10, 2024:
|
Number of Shares:
|
5,150,000
shares
|
|
|
|
Purchase Price:
|
$0.05 per
share
|
|
|
|
Warrants:
|
2,575,000 share
purchase warrants to purchase 2,575,000 shares
|
|
|
|
Warrant Exercise
Price:
|
$0.075 for a one year
period
|
|
|
|
Number of
Placees:
|
29 placees
|
|
Insider / Pro Group Participation:
|
|
|
|
|
|
|
Placees
|
# of Placee
(s)
|
Aggregate # of
Shares
|
|
|
|
|
Aggregate Existing
Insider
Involvement:
|
2
|
1,000,000
|
|
Aggregate Pro Group
Involvement:
|
4
|
730,000
|
|
Aggregate
Cash
Amount
|
Aggregate
#
of
Shares
|
Aggregate
#
of
Warrants
|
|
Finder's Fee:
|
$9,200
|
N/A
|
N/A
|
The Company issued a news release on April 25, 2024, confirming closing of the private
placement. [Note that in certain circumstances the Exchange
may later extend the expiry date of the warrants, if they are less
than the maximum permitted term.]
_______________________________________
BULLETIN V2024-1304
SILVER X MINING CORP. ("AGX")
BULLETIN TYPE:
Private Placement-Non-Brokered
BULLETIN DATE:
May 3, 2024
TSX Venture
Tier 2 Company
TSX Venture Exchange has accepted for filing documentation with
respect to a Non-Brokered Private Placement announced on
March 21, 2024:
|
Number of Shares:
|
27,777,776
shares
|
|
|
|
Purchase Price:
|
$0.18 per
share
|
|
|
|
Warrants:
|
13,888,886 share
purchase warrants to purchase 13,888,886 shares
|
|
|
|
Warrant Exercise
Price:
|
$0.30 for a three year
period
|
|
|
|
Number of
Placees:
|
70 placees
|
|
Insider / Pro Group Participation:
|
|
|
|
|
|
|
Placees
|
# of Placee
(s)
|
Aggregate # of
Shares
|
|
|
|
|
Aggregate Existing
Insider
Involvement:
|
2
|
12,627,828
|
|
Aggregate Pro Group
Involvement:
|
N/A
|
N/A
|
|
Aggregate
Cash
Amount
|
Aggregate
#
of
Shares
|
Aggregate
#
of
Warrants
|
|
Finder's
Fee:
|
$70,100.60
|
N/A
|
382,843
|
Finder's Warrants Terms: Each warrant entitles the holder to
purchase one common share at the price of $0.30 for period of three years from the date of
issuance.
The Company issued a news release on April 12, 2024, confirming closing of the private
placement. [Note that in certain circumstances the Exchange
may later extend the expiry date of the warrants, if they are less
than the maximum permitted term.]
_______________________________________
BULLETIN V2024-1305
SIMPLY SOLVENTLESS CONCENTRATES LTD.
("HASH")
BULLETIN TYPE: Private
Placement-Non-Brokered
BULLETIN DATE: May 3, 2024
TSX Venture Tier 2
Company
TSX Venture Exchange has accepted for filing documentation with
respect to a Non-Brokered Private Placement announced on
March 28, 2024 and April 8, 2024:
|
Number of Shares:
|
5,333,334
Units
|
|
|
|
Purchase Price:
|
$0.15 per
Unit
|
|
|
|
Warrants:
|
5,333,334 Share
Purchase Warrants to purchase 5,333,334 Shares
|
|
|
|
Warrant Exercise
Price:
|
$0.20 for a Three Year
Period
|
|
|
|
Number of
Placees:
|
39 Placees
|
|
Insider / Pro Group Participation:
|
|
|
|
|
|
|
Placees
|
# of Placee
(s)
|
Aggregate # of
Units
|
|
|
|
|
Aggregate Existing
Insider Involvement:
|
4
|
660,232
|
|
Aggregate Pro Group
Involvement:
|
1
|
200,000
|
|
Aggregate
Cash
Amount
|
Aggregate
#
of
Shares
|
Aggregate
#
of
Warrants
|
|
Finder's Fee:
|
N/A
|
N/A
|
N/A
|
Finder's Warrants Terms:
N/A
The Company issued a news release on April 17, 2024 confirming closing of the private
placement. Note that in certain circumstances the Exchange may
later extend the expiry date of the warrants, if they are less than
the maximum permitted term.
_______________________________________
BULLETIN V2024-1306
SPRUCE RIDGE RESOURCES LTD. ("SHL")
BULLETIN TYPE:
Property-Asset or Share Purchase Agreement
BULLETIN DATE:
May 3, 2024
TSX Venture
Tier 2 Company
TSX Venture Exchange has accepted for filing documentation with
respect to the arm's length acquisition of a 100% interest in the
Shamrock Nickel Sulphide Property (the "Property"), located
near Medford in southwest
Oregon, USA, pursuant to a
purchase agreement (the "Agreement") between Spruce Ridge
Resources Ltd. (the "Company") and an arm's length vendor
(the "Vendor").
Pursuant to the terms of the Agreement and as consideration for
the acquisition of the Property, the Company on closing paid
$148,949 and issued 2,500,000 common
shares in the capital of the Company to the Vendor.
The Vendor will retain a 2.0% net smelter returns royalty (the
"NSR") on the Property. The Company will have the option to
buy back 50% (1.0%) of such NSR for consideration of $1,000,000.
For further details, please refer to the Company's news releases
dated March 11, 2024 and April 26, 2024.
_______________________________________
BULLETIN V2024-1307
STILLWATER CRITICAL MINERALS
CORP. ("PGE")
BULLETIN TYPE: Private
Placement-Non-Brokered
BULLETIN DATE: May 3, 2024
TSX Venture Tier 2
Company
TSX Venture Exchange has accepted for filing documentation with
respect to a Non-Brokered Private Placement announced on
March 28, 2024 and April 22, 2024:
|
Number of Shares:
|
27,798,000
shares
|
|
|
|
Purchase Price:
|
$0.14 per
share
|
|
|
|
Warrants:
|
13,899,000 share
purchase warrants to purchase 13,899,000 shares
|
|
|
|
Warrant Exercise
Price:
|
$0.21 for a three-year
period, subject to acceleration
|
|
|
|
Number of
Placees:
|
66 placees
|
|
Insider / Pro Group
Participation:
|
|
|
|
|
|
|
Placees
|
# of Placee
(s)
|
Aggregate # of
Shares
|
|
|
|
|
Aggregate Existing
Insider
Involvement:
|
5
|
2,017,142
|
|
Aggregate Pro Group
Involvement:
|
2
|
858,000
|
|
Aggregate
Cash
Amount
|
Aggregate
#
of
Shares
|
Aggregate
#
of
Warrants
|
|
Finder's
Fee:
|
$64,582.56
|
N/A
|
461,304
|
Finder's Warrants Terms: Each finder warrant is non-transferable
and entitles the holder to purchase one common share at the price
of $0.21 for a period of 3 years from
the date of issuance subject to acceleration.
The Company issued a news release on May
1, 2024, confirming the closing of the private placement.
Note that in certain circumstances, the Exchange may later extend
the expiry date of the warrants if they are less than the maximum
permitted term.
_______________________________________
BULLETIN V2024-1308
SUN SUMMIT MINERALS CORP. ("SMN")
BULLETIN
TYPE: Private Placement-Non-Brokered
BULLETIN
DATE: May 3, 2024
TSX
Venture Tier 2 Company
TSX Venture Exchange has accepted for filing documentation with
respect to a Non-Brokered Private Placement announced March 11, 2024 and April
2, 2024:
|
Number of Shares:
|
25,000,000 common
shares
|
|
|
|
Purchase Price:
|
$0.10 per common
share
|
|
|
|
Warrants:
|
12,500,000 share
purchase warrants to purchase 12,500,000 common shares
|
|
|
|
Warrant Exercise
Price:
|
$0.13 for a two-year
period
|
|
|
|
Number of
Placees:
|
58 placees
|
|
Insider / Pro Group
Participation:
|
|
|
|
|
|
|
Placees
|
# of Placee
(s)
|
Aggregate # of
Shares
|
|
|
|
|
Aggregate Existing
Insider
Involvement:
|
3
|
770,000
|
|
Aggregate Pro Group
Involvement:
|
4
|
780,000
|
|
Aggregate
Cash
Amount
|
Aggregate
#
of
Shares
|
Aggregate
#
of
Warrants
|
|
Finder's
Fee:
|
$21,805.00
|
N/A
|
218,050
|
Finder's Warrants Terms: Each warrant entitles the holder to
purchase one common share at the price of $0.10 for period of 2 years from the date of
issuance.
The Company issued a news release on April 25, 2024, confirming closing of the private
placement. Note that in certain circumstances the Exchange may
later extend the expiry date of the warrants, if they are less than
the maximum permitted term.
________________________________________
BULLETIN V2024-1309
VOLCANIC GOLD MINES INC. ("VG'')
BULLETIN TYPE:
Warrant Term Amendment
BULLETIN DATE: May 3, 2024
TSX Venture Tier 2
Company
Pursuant to the Company's press release dated April 5, 2024, TSX Venture Exchange has accepted
an amendment to the 1,558,550 common share purchase warrants
("Warrants") originally issued pursuant to the Private Placement
announced on September 28, 2020:
|
Number of Amended
Warrants:
|
1,558,550
|
|
|
|
Original Expiry
Date:
|
April 20, 2022
(previously extended to April 19, 2024)
|
|
|
|
New Expiry Date:
|
April 18,
2025
|
_______________________________________
BULLETIN V2024-1310
VOLCANIC GOLD MINES INC. ("VG'')
BULLETIN TYPE:
Warrant Term Amendment
BULLETIN DATE: May 3, 2024
TSX Venture Tier 2
Company
Pursuant to the Company's press release dated April 5, 2024, TSX Venture Exchange has accepted
an amendment to the 6,273,250 common share purchase warrants
("Warrants") originally issued pursuant to the Prospectus Offering
announced on September 28, 2020:
|
Number of Amended
Warrants:
|
6,273,250
|
|
|
|
Original Expiry
Date:
|
April 20, 2022
(previously extended to April 19, 2024)
|
|
|
|
New Expiry Date:
|
April 18,
2025
|
_______________________________________
SOURCE TSX Venture Exchange